Latest Releases

A new study from Northwestern Medicine reveals a troubling rise in severe maternal health issues and birth complications in Illinois from 2016 to 2023, closely linked to increases in chronic health conditions affecting pregnancy, such as high blood pressure, gestational diabetes, mental health disorders and especially obesity, which saw the largest increase in annual rates.

Northwestern University scientists have developed a new protective coating that significantly extends the life of perovskite solar cells, making them more practical for applications outside the lab.

Can a personalized diet help improve health and prevent chronic diseases? That’s the question at the center of the ongoing nationwide study, Nutrition for Precision Health (NPH) — the largest precision-nutrition research effort of its kind — which is researching how individuals respond to different foods.

As the holiday season approaches, it’s a time many associate with joy and togetherness. Yet for millions, it’s a period marked by loneliness. There are things people can do to feel better during this season, Northwestern University experts say.
* Media Advisory

The Black Arts Consortium, Northwestern University’s hub for Black art and cultural exploration, is hosting the first-ever James Baldwin Centennial Symposium, Nov 22 to 24. The three-day forum is dedicated to celebrating the life, work and legacy of the legendary writer and social critic.
* Media Advisory

Northwestern’s Wirtz Center for the Performing Arts kicks off its annual MFA Collaboration series on Friday, Nov. 22 with a gripping drama about four roommates whose Sunday morning drinks lead to explosive revelations. Productions continue into the winter and spring quarters of 2025.

Between 50-75% of people who start taking weight-loss medications like Ozempic or Wegovy — called GLP-1 drugs — stop using them within a year. Northwestern Medicine cardiologist Dr. Sadiya Khan wants to figure out why, what the harms may be of stopping therapy prematurely, and how to help patients continue their therapy.
* Media Advisory

With its ability to improve neuron health, experimental drug NU-9 has already shown promise in reversing amyotrophic lateral sclerosis (ALS). Now, the National Institute on Aging (NIA) has provided approximately $7.3 million to fund exploration into the Northwestern University-invented drug’s effectiveness in other neurodegenerative diseases.

A Northwestern University-led team of engineers has developed a new type of wearable device that stimulates skin to deliver various complex sensations. The thin, flexible device could help people with visual impairments ‘feel’ surroundings.

In an era where demonstrations involving force are growing in number and viewed as a likely source of increased collective violence, the scientific understanding of the correlation between protests and the social media communications of leaders remains debated.